Soligenix (SNGX)
(Real Time Quote from BATS)
$3.81 USD
-0.20 (-4.99%)
Updated Sep 19, 2024 03:12 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Soligenix Inc. [SNGX]
Reports for Purchase
Showing records 61 - 80 ( 98 total )
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage-Coverage of Soligenix Terminated
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Initiating coverage with a BUY rating and a $6.75 price target.
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Termination of Coverage
Provider: RODMAN & RENSHAW, CO.